Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
48.88
-0.56 (-1.13%)
At close: Mar 28, 2025, 4:00 PM
49.04
+0.16 (0.33%)
After-hours: Mar 28, 2025, 7:50 PM EDT
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $3.00 billion as of March 28, 2025. Its market cap has increased by 70.49% in one year.
Market Cap
3.00B
Enterprise Value
2.45B
1-Year Change
70.49%
Ranking
Category
Stock Price
$48.88
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $3.00B, an increase of 1,649.54%. That is a compound annual growth rate of 39.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 3.00B | 30.43% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 740.67B |
| UnitedHealth Group | 475.56B |
| Johnson & Johnson | 394.52B |
| AbbVie | 359.46B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 228.41B |
| AstraZeneca | 225.00B |
| Merck & Co. | 223.85B |